Allianz Asset Management GmbH - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAB1. A total of 13 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2019$14,606,000
+64.4%
8,300,000
+26.7%
0.01%
+55.6%
Q1 2018$8,887,000
-63.1%
6,550,000
-70.0%
0.01%
-52.6%
Q4 2017$24,057,00021,830,0000.02%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 12,355,000$14,956,0001.86%
Redmile Group, LLC 19,000,000$22,845,0000.92%
LINDEN ADVISORS LP 24,075,000$29,093,0000.81%
TENOR CAPITAL MANAGEMENT Co., L.P. 9,000,000$10,865,0000.72%
CSS LLC/IL 6,835,000$8,266,0000.55%
Graham Capital Management, L.P. 10,000,000$12,170,0000.54%
Verition Fund Management LLC 5,880,000$7,118,0000.51%
SG Americas Securities, LLC 120,000$14,527,0000.13%
Nicholas Investment Partners, LP 930,000$1,124,0000.12%
OAKTREE CAPITAL MANAGEMENT LP 6,000,000$7,262,0000.07%
View complete list of ARRAY BIOPHARMA INC shareholders